Facility Design and Expansion: Commissioning for Innovation - Many biotech facilities consume more than tenfold the amount of energy used by other institutions. Design a space that is right for your

ADVERTISEMENT

Facility Design and Expansion: Commissioning for Innovation
Many biotech facilities consume more than tenfold the amount of energy used by other institutions. Design a space that is right for your business.


BioPharm International
Volume 19, Issue 5

Consider that both the vivarium and pilot facility should have 100 percent back-up, because their operations are time-sensitive and critical to the central function of the entire organization. In addition to standby equipment, strategies to share equipment or reduce services for less critical functions are often a cost effective and dependable means of ensuring 100 percent uptime for critical facilities. For example, use a laboratory air handling unit to back up a vivarium system in case of failure or maintenance, provided that the laboratory function can accept a temporary reduction in service.

A number of additional system redundancies are also required to ensure that the critical elements of a biotechnology facility, specifically the laboratory space, are adequately prepared for the event of an unexpected power failure or system shut down. This includes information technology safeguards, security, fire and life-safety equipment, and various procedures for operations, maintenance, monitoring, controls, and disaster recovery.

As the biotechnology industry continues to play an increasing role in the delivery of cutting-edge products and technologies, modern biotechnology firms continue to pursue new research programs and adopt modern technologies that will help them remain agile and ahead of the intense competition. Their success in implementing these new programs and technologies in the years ahead will be contingent upon the delivery of flexible and energy efficient design concepts that allow cost-effective expansion efforts.

Mark N. Yakren, PE, is Senior Vice President, Syska Hennessy Group, 11 West 42nd St., New York, NY, 10036, tel 800.328.1600; fax 212.556.3242,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pandemic Vaccine Facility Dedicated in Texas
September 19, 2014
GSK Fined in China Bribery Scandal
September 19, 2014
Guideline Delineates How to Implement GS1 Standards to Support DSCSA
September 19, 2014
GPhA Supports Restricted Access Bill
September 18, 2014
Baxter Initiates Voluntary Recall of Potassium Chloride Injection
September 17, 2014
Author Guidelines
Source: BioPharm International,
Click here